NCT03420937View on ClinicalTrials.gov

Deep Neuromuscular Block During General Anaesthesia in Robotic Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

138

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

June 30, 2017

Study Completion Date

August 31, 2017

Conditions
Observation of Neuromuscular BlockComplication of Ventilation TherapyPostoperative Recovery
Interventions
DRUG

Sugammadex

Deep neuromuscular block provided by rocuronium to PTC 1-2. Reversal of the block with sugammadex.

DRUG

Neostigmine, Atropin Biotika

Standard neuromuscular block provided by rocuronium to TOF-count 1-2. Reversal of the block with neostigmine.

Trial Locations (1)

77520

Dept. of Anesthesiology and Intensive Care Medicine, University Hospital Olomouc, Olomouc

All Listed Sponsors
collaborator

Palacky University

OTHER

lead

University Hospital Olomouc

OTHER

NCT03420937 - Deep Neuromuscular Block During General Anaesthesia in Robotic Surgery | Biotech Hunter | Biotech Hunter